Risk factors for bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli in a turkish hospital

Journal of Infection in Developing Countries

Volumn 7, Issue 7, 2013, Pages 507-512

  Kaya, Onur ^a   Akcam, Fusun Zeynep ^a   Gonen, Ibak ^a   Unal, Onur ^a   Ceylan, Tennure ^a  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

Author keywords

Bacteremia; Escherichia coli; Extended spectrum beta lactamase; Risk factors

Indexed keywords

CEPHALOSPORIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BACTEREMIA; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RISK FACTOR; URINARY CATHETER;

AGED; BACTEREMIA; BETA-LACTAMASES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TERTIARY CARE CENTERS; TURKEY;

EID: 84880308101     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.2788     Document Type: Article

References (17)

1. Hsieh CJ, Shen YH, Hwang KP (2010) Clinical implications, risk factors and mortality following community-onset bacteremia caused by extended-spectrum beta-lactamase (ESBL) and non-ESBL producing Escherichia coli. J Microbiol Immunol Infect 43: 240-248.
2. Paterson DL (2006) Resistance in Gram-negative bacteria: Enterobacteriaceae. Am J Infect Control 34 (5 Suppl 1): S20-28.
3. Doernberg SB, Winston LG (2012) Risk factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli in an urban county hospital. Am J Infect Control 40: 123-127.
4. Freeman JT, McBride SJ, Nisbet MS, Gamble GD, Williamson DA, Taylor SL, Holland DJ (2012) Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes. Int J Infect Dis 16: e371-374.
5. Tumbarello M, Sali M, Trecarichi EM, Leone F, Rossi M, Fiori B, De Pascale G, D'lnzeo T, Sanguinetti M, Fadda G, Cauda R, Spanu T (2008) Bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. Antimicrob Agents Chemother 52: 3244-3252.
6. Clinical and Laboratory Standards Institue (CLSI) (2010) Performance standards for antimicrobial susceptibility testing: 20th informational supplement. Twentieth informational supplement. M100-S20.
7. Stryjewski ME, Boucher HW (2009) Gram-negative bloodstream infections. Int J Antimicrob Agents 34(Suppl 4): S21-25.
8. Rodriguez-Bano J, Navarro MD, Romero L, Muniain MA, Cueto M, Galvez J, Perea EJ, Pascual A (2008) Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamases-producing Escherichia coli. Clin Microbiol Infect 14: 180-183.
9. Sheng WH, Liao CH, Lauderdale TL, Ko WC, Chen YS, Liu JW, Lau YJ, Wang LH, Liu KS, Tsai TY, Lin SY, Hsu MS, Hsu LY, Chang SC (2010) A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Int J Infect Dis 14: e764-769.
10. Quirante OF, Cerrato SG, Pardos SL (2011) Risk factors for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Braz J Infect Dis 15: 370-376.
11. Wu UI, Yang CS, Chen WC, Chen YC, Chang SC (2010) Risk factors for bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli. J Microbiol Immunol Infect 43: 310-316.
12. Kang CI, Chung DR, Ko KS, Peck KR, Song JH; Korean Network for Study of Infectious Diseases (2012) Risk factors for infection and treatment outcome of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy. Ann Hematol 91: 115-121.
13. Trecarichi EM, Tumbarello M, Spanu T, Caira M, Fianchi L, Chiusolo P, Fadda G, Leone G, Cauda R, Pagano L (2009) Incidence and clinical impact of extended-spectrum beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Infect 58: 299-307.
14. Tumbarello M, Spanu T, Sanguinetti M, Citton R, Montuori E, Leone F, Fadda G, Cauda R (2006) Bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother 50: 498-504.
15. Wang SS, Lee NY, Hsueh PR, Huang WH, Tsui KC, Lee HC, Wu CJ, Chang CM, Huang CC, Huang CF, Ko WC (2011) Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae. J Microbiol Immunol Infect 44: 282-288.
16. Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, Ki HK, Son JS, Lee SS, Kim YS, Jung SI, Kim SW, Chang HH, Ryu SY, Kwon KT, Lee H, Moon C, Shin SY; Korean Network for Study of Infectious Diseases (2010) Risk factors and treatments outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli. Int J Antimicrob Agents 36: 284-287.
17. Lee JA, Kang CI, Joo EJ, Ha YE, Kang SJ, Park SY, Chung DR, Peck KR, Ko KS, Lee NY, Song JH (2011) Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Microb Drug Resist 17: 267-273.